J Castillo1, A Dávalos, M Noya. 1. Department of Neurology, Complejo Hospitalario Universitario, Hospital General de Galicia, Santiago de Compostela, Spain.
Abstract
OBJECTIVE: To examine whether hyperthermia aggravates cerebral injury in acute ischemia by an excitotoxic mechanism, we studied the relationship between body temperature on admission and CSF concentrations of neuroexcitatory amino acids in 128 patients with acute ischemic stroke of less than 24 h duration. METHODS: Stroke worsening was defined as the percent change between the Canadian Stroke Scale (CSS) at 48 h and the CSS on admission. Infarct volume was measured on days 4-7 on cranial computed tomography. Excitatory amino acids were analyzed using HPLC. RESULTS: Glutamate concentration [median (min.-max.)] was 11 (2-19) micromol/l in hyperthermic patients (body temperature >37.5 degreesC) and 5 (2-22) micromol/l in normothermic patients (p < 0.0001). Glycine concentration in hyperthermic and normothermic patients was 16 (3-21) micromol/l and 9 (3-50) micromol/l, respectively (p < 0.0001). Glutamate was significantly higher in patients with hyperthermia only during the first 12 h after the onset of symptoms. The CSF concentrations of glutamate (r = 0.52; p < 0.0001) and glycine (r = 0.62; p < 0.0001) correlated with body temperature. Body temperature was significantly related to stroke worsening and infarct size, but this effect was dependent on the glutamate effect. CONCLUSION: Glutamate and glycine release during the acute phase of cerebral ischemia could be responsible for the increased brain damage in hyperthermia.
OBJECTIVE: To examine whether hyperthermia aggravates cerebral injury in acute ischemia by an excitotoxic mechanism, we studied the relationship between body temperature on admission and CSF concentrations of neuroexcitatory amino acids in 128 patients with acute ischemic stroke of less than 24 h duration. METHODS:Stroke worsening was defined as the percent change between the Canadian Stroke Scale (CSS) at 48 h and the CSS on admission. Infarct volume was measured on days 4-7 on cranial computed tomography. Excitatory amino acids were analyzed using HPLC. RESULTS:Glutamate concentration [median (min.-max.)] was 11 (2-19) micromol/l in hyperthermic patients (body temperature >37.5 degreesC) and 5 (2-22) micromol/l in normothermic patients (p < 0.0001). Glycine concentration in hyperthermic and normothermic patients was 16 (3-21) micromol/l and 9 (3-50) micromol/l, respectively (p < 0.0001). Glutamate was significantly higher in patients with hyperthermia only during the first 12 h after the onset of symptoms. The CSF concentrations of glutamate (r = 0.52; p < 0.0001) and glycine (r = 0.62; p < 0.0001) correlated with body temperature. Body temperature was significantly related to stroke worsening and infarct size, but this effect was dependent on the glutamate effect. CONCLUSION:Glutamate and glycine release during the acute phase of cerebral ischemia could be responsible for the increased brain damage in hyperthermia.
Authors: Daijiro Hori; Allen D Everett; Jennifer K Lee; Masahiro Ono; Charles H Brown; Ashish S Shah; Kaushik Mandal; Joel E Price; Laeben C Lester; Charles W Hogue Journal: Ann Thorac Surg Date: 2015-07-07 Impact factor: 4.330
Authors: José Castillo; María Isabel Loza; David Mirelman; José Brea; Miguel Blanco; Tomás Sobrino; Francisco Campos Journal: J Cereb Blood Flow Metab Date: 2015-10-02 Impact factor: 6.200
Authors: Symeon Missios; Brent T Harris; Carter P Dodge; Michael K Simoni; Beth A Costine; Ying-Lung Lee; Patricia B Quebada; Simon C Hillier; Leslie B Adams; Ann-Christine Duhaime Journal: J Neurotrauma Date: 2009-11 Impact factor: 5.269
Authors: Kameshwar Prasad; Subhash Kaul; M V Padma; S P Gorthi; Dheeraj Khurana; Asha Bakshi Journal: Ann Indian Acad Neurol Date: 2011-07 Impact factor: 1.383